U.S. supplement manufacturer Vitaloix Laboratories will make its much anticipated foray into the Chinese marketplace in late 2007, having appointed XPD Pharma as the distributor for its Flexcerin⢠supplement. Flexcerin⢠has already established a successful consumer presence in both the North American and European marketplaces. In a press release made available on Wednesday, the company said the product which is designed to promote healthy mobile joint function and connective tissue will be distributed under the co-promotion agreement of both parties. The company said that this distribution agreement for China will be for an initial period of two years, but could then be extended by mutual agreement. Recent statistical data shows that more than 355 million people View the rest of this article
Friday, July 27, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment